Victor Cervera-Carrascón successfully defended his PhD thesis titled "Enabling PD-1 axis inhibitors against solid tumours with engineered adenoviruses armed with TNFa and IL-2".
Dafne Quixabeira receives two year grant from the Finnish Cultural Foundation
Tatiana Kudling receives four year University of Helsinki -funded doctoral candidate position in Doctoral Programme in Clinical Research.
Joao Santos successfully defended his PhD thesis titled "Overcoming safety and efficacy challenges of adoptive t-cell therapy with cytokine-coding oncolytic adenoviruses".
Dafne Quixabeira receives one year grant from the Finnish Cultural Foundation
Riikka Havunen successfully defended her PhD thesis titled "Enhancing Adoptive Cell Therapy of Solid Tumours with Armed Oncolytic Adenoviruses".
CGTG and University of Helsinki win a position as a partner organisation in EU H2020-MSC-ITN-EID project STACCATO running between 2019-2022.
Victor Cervera-Carrascon was awarded an oral presentation at European Congress of Immunology (Amsterdam 2-5.9.2018); abstract ranked within top 1%.
Riikka Havunen was awarded oral presentation at CIMT annual meeting 2018.
Minna Oksanen celebrates her 10th anniversary in CGTG.
Sadia Zafar receives three year University of Helsinki -funded doctoral candidate position in Doctoral Programme in Clinical Research.
GeneQuine Biotherapeutics, a company founded by Kilian Guse who did his PhD and a post-doc at CGTG, acquired by Flexion for 64 mUSD.
CGTG winter retreat 2017 celebrated with TILT Biotherapeutics: tennis and dinner
Professor Hemminki interviewed on YLE1 Perjantai.
Víctor Cervera-Carrascón and João Santos were among the oral presenters of the selected abstracts at Netherlands Society of Gene and Cell Therapy Spring Symposium 2017.
Mikko Siurala successfully defended his PhD thesis titled "Improving adenovirus-based immunotherapies for treatment of solid tumors".
Prof Hemminki's book "Crossing the Valley of Death with Advanced Cancer Therapy" enters the finals for "Science book of the Year", The Federation of Finnish Learned Societies".
Kristian Taipale successfully defended his PhD thesis titled "Immunologic effects of cancer therapy with oncolytic adnoviruses".
Mikko Siurala was awarded oral presentation at the International Conference on Oncolytic Virus Therapeutics in Vancouver, Canada.
Finnish Cancer Institute Symposium 2016 poster award won by Victor Cervera-Carrascon.
Professor Hemminki discusses the harmful effects of overregulation of clinical trials in Helsingin Sanomat.
Siri Tähtinen successfully defended her PhD thesis titled "Combining Oncolytic Immunotherapies to Break Tumor Resistance".
Mari Hirvinen successfully defended her PhD thesis titled "Immunological boosting and personalization of oncolytic virotherapies for cancer treatment".